Ultrahypofractionated Proton Radiation Therapy in the Treatment of Low and Intermediate-Risk Prostate Cancer-5-Year Outcomes-Reference-Cited by-同舟云学术

Ultrahypofractionated Proton Radiation Therapy in the Treatment of Low and Intermediate-Risk Prostate Cancer-5-Year Outcomes

Published:2021-07 Issue:4 Volume:110 Page:1090-1097
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Kubeš Jiří,Haas Alexandra,Vondráček Vladimír,Andrlík Michal,Navrátil Matěj,Sláviková Silvia,Vítek Pavel,Dědečková Kateřina,Prausová Jana,Ondrová Barbora,Vinakurau Štěpán,Grebenyuk Alexander,Doležal Tomáš,Velacková Barbora,Rosina Jozef

Funder

European Regional Development Fund

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference22 articles.

1. Comparative toxicities and cost of intensity-modulated radiotherapy, proton radiation, and stereotactic body radiotherapy among younger men with prostate cancer;Pan;J Clin Oncol,2018

2. Five-year biochemical results, toxicity, and patient-reported quality of life after delivery of dose-escalated image guided proton therapy for prostate cancer;Bryant;Int J Radiat Oncol Biol Phys,2016

3. Long-term outcomes in patients treated with proton therapy for localized prostate cancer;Takagi;Cancer Med,2017

4. Stereotactic body radiation therapy for patients with early-stage prostate cancer;Linney;Anticancer Res,2018

5. Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer;Kishan;JAMA Netw Open,2019

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis;Radiotherapy and Oncology;2024-06

2. Patients’ needs in proton therapy: A survey among ten European facilities;Clinical and Translational Radiation Oncology;2023-11

3. Variation of the relative biological effectiveness with fractionation in proton therapy: Analysis of prostate cancer response;Medical Physics;2023-10-11

4. 5-Years Analysis of Effectivity and Toxicity of Ultra-Hypofractionated Proton Radiotherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer—A Retrospective Analysis;Cancers;2023-09-15

5. Image-Guided Proton Therapy: A Comprehensive Review;Cancers;2023-04-29